INS and type 2 diabetes mellitus: Results showed that the elevated fasting S-TBAs levels within the normal range were significantly associated with reduced fasting and systemic insulin sensitivity, impaired islet β-cell function and increased blood glucose after glucose stimulation in T2DM patients, suggesting that the regulation of fasting S-TBAs may be a therapeutic target for T2DM (Wang et al., 2020).